This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (29)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Men's Health  • Prostate Disease  • Oncology  • Prostate Cancer  • Obesity  • Alert me on articles by topic  Social Bookmarking   What's this?

Lionel L. Bañez, MD; Robert J. Hamilton, MD, MPH; Alan W. Partin, MD, PhD; Robin T. Vollmer, MD; Leon Sun, MD, PhD; Carmen Rodriguez, MD, MPH; Yiting Wang, PhD; Martha K. Terris, MD; William J. Aronson, MD; Joseph C. Presti Jr, MD; Christopher J. Kane, MD; Christopher L. Amling, MD; Judd W. Moul, MD; Stephen J. Freedland, MD

JAMA. 2007;298(19):2275-2280.

Context  Recent studies have suggested that obese men have lower serum prostate-specific antigen (PSA) concentrations than nonobese men. Because men with higher body mass index (BMI) have greater circulating plasma volumes, lower PSA concentrations among obese men may be due to hemodilution.

Objective  To determine the association between hemodilution and PSA concentration in obese men with prostate cancer.

Design, Setting, and Participants  Retrospective study of men who underwent radical prostatectomy for prostate adenocarcinoma from 1988 to 2006, using data from the databases of the Shared Equal Access Regional Cancer Hospital (n = 1373), Duke Prostate Center (n = 1974), and Johns Hopkins Hospital (n = 10 287). Multivariate linear regression models adjusting for clinicopathological characteristics were used to analyze the main outcome measures.

Main Outcome Measures  Associations between BMI and mean adjusted PSA concentrations, mean plasma volume, and mean adjusted PSA mass (total circulating PSA protein, calculated as PSA concentration multiplied by plasma volume), assessed by determining P values for trend.

Results  After controlling for clinicopathological characteristics, higher BMI was significantly associated with higher plasma volume (P < .001 for trend) and lower PSA concentrations (P  .02 for trend) in all cohorts. In 2 of the 3 cohorts, PSA mass did not change significantly with increasing BMI. In the third cohort, higher BMI was associated with increased PSA mass (P < .001 for trend), but only between BMI category less than 25 and the other categories.

Conclusions  In men undergoing radical prostatectomy, higher BMI was associated with higher plasma volume; hemodilution may therefore be responsible for the lower serum PSA concentrations among obese men with prostate cancer. Prospective studies are needed to evaluate this association in screened populations.

Author Affiliations: Division of Urologic Surgery and the Duke Prostate Center, Department of Surgery (Drs Bañez, Hamilton, Sun, Moul, and Freedland) and Department of Pathology (Drs Vollmer and Freedland), Duke University Medical Center, Durham, North Carolina; Urology Section (Drs Bañez, Hamilton, and Freedland) and Department of Pathology (Dr Vollmer), Veterans Affairs Medical Center, Durham; Division of Urology, Department of Surgery, University of Toronto, Toronto, Ontario, Canada (Dr Hamilton); Department of Urology, the James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutes, Baltimore, Maryland (Dr Partin); Department of Epidemiology and Surveillance Research, American Cancer Society, Atlanta, Georgia (Drs Rodriguez and Wang); Urology Section, Veterans Affairs Medical Center, Augusta, and Section of Urology, Medical College of Georgia, Augusta (Dr Terris); Urology Section, Veterans Affairs Greater Los Angeles Healthcare System and Department of Urology, University of California, Los Angeles, School of Medicine (Dr Aronson); Department of Urology, Stanford University School of Medicine and Urology Section, Veterans Affairs Medical Center, Palo Alto, California (Dr Presti); Urology Section, Veterans Affairs Medical Center, San Francisco, and Department of Urology, University of California, San Francisco, School of Medicine (Dr Kane); and Department of Urology, University of Alabama, Birmingham (Dr Amling).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hemodilution of Prostate-Specific Antigen Levels Among Obese Men
Rundle et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:2343-2343.
FULL TEXT  

Association of Diabetes and Body Mass Index with Levels of Prostate-Specific Antigen: Implications for Correction of Prostate-Specific Antigen Cutoff Values?
Muller et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:1350-1356.
ABSTRACT | FULL TEXT  

Serum Prostate-Specific Antigen Hemodilution Among Obese Men Undergoing Screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
Grubb et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:748-751.
ABSTRACT | FULL TEXT  

Randomized Trials of Antioxidant Supplementation for Cancer Prevention: First Bias, Now Chance--Next, Cause
Gann
JAMA 2009;301:102-103.
FULL TEXT  

Body Composition, Abdominal Fat Distribution, and Prostate-Specific Antigen Test Results
Rundle et al.
Cancer Epidemiol. Biomarkers Prev. 2009;18:331-336.
ABSTRACT | FULL TEXT  

Associations of Lifestyle and Physiologic Factors with Prostate-Specific Antigen Concentrations: Evidence from the National Health and Nutrition Examination Survey (2001-2004)
Parekh et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2467-2472.
ABSTRACT | FULL TEXT  

Obesity and PSA Levels
JWatch General 2007;2007:2-2.
FULL TEXT  

Why Do Obese Men Have Lower PSA Concentrations?
JWatch Oncology and Hematology 2007;2007:1-1.
FULL TEXT